STAGE IIC COLON CANCER AJCC V8
Clinical trials for STAGE IIC COLON CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIC COLON CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIC COLON CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo immunotherapy aims to shrink colon tumors before surgery
Disease control Recruiting nowThis study tests whether giving two immunotherapy drugs (botensilimab and balstilimab) before surgery can shrink tumors and improve outcomes for people with advanced colon cancer that can be removed. About 100 adults with stage IIB to IIIC colorectal cancer will receive the drugs…
Matched conditions: STAGE IIC COLON CANCER AJCC V8
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jul 02, 2026 05:00 UTC
-
Immunotherapy after surgery may keep colon cancer from returning
Disease control Recruiting nowThis trial tests whether the immunotherapy drug toripalimab can lower the chance of cancer coming back after surgery in people with mismatch repair deficient (dMMR) stage IIB, IIC, or III colon cancer. About 40 participants will receive toripalimab intravenously. The study will t…
Matched conditions: STAGE IIC COLON CANCER AJCC V8
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC